Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
12/2005
12/07/2005EP1601670A1 Arylvinylazacycloalkane compounds and methods of preparation and use thereof
12/07/2005EP1601667A2 Crystalline and amorphous solids of pantoprazole and processes for their preparation
12/07/2005EP1601666A2 New neuropeptide y y5 receptor antagonists
12/07/2005EP1601665A2 Urea derivatives
12/07/2005EP1601664A1 Biaryltetrahydroisoquinoline piperidines as selective mch receptor antagonists for the treatment of obesity and related disorders
12/07/2005EP1601659A1 Pyrimidin-2-one compounds and their use as dopamine d3 receptor ligands
12/07/2005EP1601657A1 Pyrazole modulators of atp-binding cassette transporters
12/07/2005EP1601656A1 Tetrahydroquinoline derivatives useful as serine protease inhibitors
12/07/2005EP1601654A1 Heterocyclic amides, method for the production thereof, substances containing said heterocyclic amides, and use thereof as pesticides
12/07/2005EP1601653A1 Process for the production of substituted nicotinic acid esters
12/07/2005EP1601358A1 2,5- and 2,6-substituted tetrahydroisoquinolines for use as 5-ht6 modulators
12/07/2005EP1601357A1 Heterocyclic kinase inhibitors: methods of use and synthesis
12/07/2005EP1501823B1 New piperidinyl-alkylamino-pyridazinone derivatives, a process for the preparation thereof and pharmaceutical compositions containing said compounds
12/07/2005EP1499607B1 4-(piperidyl- and pyrrolidyl-alkyl-ureido)-quinolines as urotensin ii receptor antagonists
12/07/2005EP1450800A4 SUBSTITUTED AMINO METHYL FACTOR Xa INHIBITORS
12/07/2005EP1399438B1 Novel heteroaryl derivatives, their preparation and use
12/07/2005EP1370258B1 Peptide deformylase inhibitors
12/07/2005EP1307449B1 1,4-dihydropyridines as bradykinin antagonists
12/07/2005EP1294711B1 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as modulators of protein kinases
12/07/2005EP1199306B1 Biarylurea derivatives
12/07/2005EP1147089B1 Phenylphenanthridines with pde-iv inhibiting activity
12/07/2005EP1097138B1 Pharmaceutical compositions comprising 2-quinolones
12/07/2005EP1077928B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1077927B1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
12/07/2005EP1067917B1 Method of treating dopaminergic and gaba-nergic disorders
12/07/2005EP0957917B1 Vitronectin receptor antagonists
12/07/2005CN1705730A Electroluminescent iridium compounds having red-orange or red emission and devices made with such compounds
12/07/2005CN1705660A New dihydro-4(1h)-pyridinone derivatives are useful in the treatment of cognitive disorders, neurodegenerative diseases and pain
12/07/2005CN1705657A Azole derivatives as antifungal agents
12/07/2005CN1705656A Method for the synthesis of a benzimidazole compound
12/07/2005CN1705649A Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents
12/07/2005CN1705647A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/07/2005CN1705645A Methylene urea derivatives as raf-kinase inhibitors
12/07/2005CN1705635A Inhibitors of histone deacetylase
12/07/2005CN1704414A 1-aryl pyrazole oxime derivatives and their preparing process and use
12/07/2005CN1704404A Tricyclic protein kinase inhibitors
12/07/2005CN1230434C Indazolyl-substituted pyrroline compounds as kinase inhibitor
12/07/2005CN1230431C Arylmethylamine derivatives for use as tryptase inhibitors
12/07/2005CN1230425C Optical active compound used as intermediate in preparing optical activity 2-imidazoline-5-thionone derivatives
12/07/2005CN1230424C Hydroxy substituted N-alkoxy hindered amine
12/07/2005CN1230421C Amide compounds and medicinal use thereof
12/07/2005CN1230416C Pharmaceutical compounds
12/07/2005CN1230174C Selective iGLuR5 receptor antagonists for the treatment of migraine
12/07/2005CN1230163C 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole in combination with estrogens
12/06/2005US6972296 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines
12/06/2005US6972295 Central nervous system disorders; psychological disorders; antiinflammatory agents; multiple sclerosis
12/06/2005US6972293 Diagnosis and treatment of anxiety, Down Syndrome, sleep, cognitive and seizure disorders, depression, overdose with benzodiazepine drugs, and enhancement of memory and alertness; gamma-aminobutyric acid (gaba)
12/06/2005US6972290 Piperazine derivatives and their use as anti-inflammatory agents
12/06/2005US6972288 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
12/06/2005CA2354606C Azabicycloalkane derivatives and therapeutic uses thereof
12/06/2005CA2325282C Use of apo b secretion/mtp inhibitors
12/06/2005CA2233975C Succinimide and maleimide cytokine inhibitors
12/06/2005CA2163115C N-substituted beta-aryl- and beta-heteroaryl-alpha-cyanoacrylamide derivatives and process for their preparation
12/06/2005CA2096528C Retroviral protease inhibitors
12/04/2005CA2568914A1 Therapeutic agents, and methods of making and using the same
12/01/2005WO2005113581A1 Substituted prolines as inhibitors of hepatitis c virus ns3 serine protease
12/01/2005WO2005113553A2 Azinyl imidazoazine and azinyl carboxamide
12/01/2005WO2005113551A1 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
12/01/2005WO2005113549A1 Substituted 2,5-diaminomethyl-1h-pyrroles
12/01/2005WO2005113543A1 Crystalline forms of a pyridinyl-sulfonamide and their use as endothelin receptor antagonists
12/01/2005WO2005113542A2 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005WO2005113541A1 Pyrrole compounds as inhibitors of erk protein kinase, synthesis thereof and intermediates thereto
12/01/2005WO2005113540A1 Isoquinoline compound and pharmaceutical use thereof
12/01/2005WO2005113539A1 3-arylsulfonyl-quinolines as 5-ht6 receptor antagonists for the treatment of cns disorders
12/01/2005WO2005113538A1 2-substituted pyrimidines and their use as pesticides
12/01/2005WO2005113537A2 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113536A2 Tri- and bi-cyclic heteroaryl histamine-3 receptor ligands
12/01/2005WO2005113535A2 Pyrazinylmethyl lactam derivatives
12/01/2005WO2005113515A1 Pyrimidines for use as plk inhibitors
12/01/2005WO2005113514A2 Substituted pyrimidines as inhibitors of bacterial type iii protein secretion systems
12/01/2005WO2005113511A1 Urea antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
12/01/2005WO2005113509A1 Novel 4-oxoquinoline compound and use thereof as hiv integrase inhibitor
12/01/2005WO2005113504A1 Cyclic amide derivatives, and their production and use as antithrombotic agents
12/01/2005WO2005113494A2 Nitrogenated heterocyclic derivatives as protein kinase modulators and use for the treatment of angiogenesis and cancer
12/01/2005WO2005112938A2 Disalt inhibitors of il-12 production
12/01/2005WO2005112932A2 Raf modulators and methods of use
12/01/2005WO2005112925A1 Aryl sulfonamides
12/01/2005WO2005112630A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof
12/01/2005WO2005095345A3 Heteroaryl guanidines as inhibitors of viral replication
12/01/2005WO2005082862A3 Benzimidazolyl derivatives as kinase inhibitors
12/01/2005WO2005065192A3 Photolabile compounds
12/01/2005WO2005060963A8 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity
12/01/2005WO2005042516A3 Ligands of melanocortin receptors and compositions and methods related thereto
12/01/2005WO2005019167A3 Melanin concentrating hormone receptor antagonist
12/01/2005WO2004101544A8 Benzyl sulfonamide derivatives as androgen receptor antagonists
12/01/2005WO2004085401A8 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity
12/01/2005WO2004080964A8 Indole derivatives useful for the treatment of diseases
12/01/2005US20050267194 Indole compounds
12/01/2005US20050267186 Minimal cardivascular and/or sedatory activity; treating pain and allodynia; selective to alpha2B and/or alpha2C adrenergic receptors in preference over alpha2A adrenergic receptors;
12/01/2005US20050267185 1,2,4-triazole derivatives, compositions, process of making and methods of use
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267160 arthritis, allergic contact dermatitis, psoriasis, asthma, rheumatoid arthritis, or stroke; using producing coronary vasodilation without significant peripheral vasodilation
12/01/2005US20050267159 Magnesium complexes of S-omeprazole
12/01/2005US20050267158 Polymorphic and amorphous forms of 2,5-dimethyl-2H-pyrazole-3-carboxylic acid {2-fluoro-5-[3-((E)-2 pyridin-2-YL-vinyl)-1H-indazol-6-ylamino]-phenyl}-amide
12/01/2005US20050267157 Magnesium-S-omeprazole
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267150 Treating Alzheimer's disease with substituted urea or thiourea-alkylamidolactone compound
12/01/2005US20050267148 Benzimidazole derivative
12/01/2005US20050267147 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
12/01/2005US20050267146 3-(4-Heteroarylcyclohexylamino)cyclopentanecarboxamides as modulators of chemokine receptors